NCT05172245 2026-03-18
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
National Cancer Institute (NCI)
Phase 1 Recruiting
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
NRG Oncology
AstraZeneca